RadOnc Smart Review

In our last episode, we established the framework for managing newly diagnosed, early-stage cervical cancer. But what happens when the surgeon calls you for a post-op consult? This is one of the most common and highest-yield scenarios you will face. Today, we're going to master the post-operative decision framework, learning exactly when to recommend observation, when to give adjuvant radiation, and when to add concurrent chemotherapy.

Welcome back to Rad Onc Smart Review, Gyn cancer series. This is Episode 1: Cervix Cancer Part 1: Staging, Workup, and Early-Stage Evidence.Today, we're laying the foundation for our entire cervical cancer curriculum. We're going to tackle the critical first steps in managing a new diagnosis: understanding the disease's background, how to properly stage a patient using the modern FIGO system, what workup is essential, and how to counsel a patient on the fundamental choice between primary surgery and primary radiation.

This is our final episode in the C.N.S. block, Episode 20C: a comprehensive Case-Based Review of Benign C.N.S. Tumors and Stereotactic Radiosurgery cases.Over the last several episodes, we've systematically dissected the evidence that defines modern C.N.S. oncology, from malignant gliomas to a wide range of benign tumors. Let's continue to put that knowledge to the test. This episode is a mock oral board examination. I will present five comprehensive case blocks. Pause after each question to formulate your own structured response before I provide the model answer and a key teaching pearl.

Welcome back to Rad Onc Smart Review, C.N.S. Cancer series. Over the last several episodes, we've systematically dissected the evidence that defines modern C.N.S. oncology. We are continuing our mock oral style review of CNS oncology. I will present comprehensive case blocks, covering different clinical scenarios and then pose a series of questions designed to test your knowledge across all core competencies. Pause after each question to formulate your own structured response before I provide the model answer and a key teaching pearl.

Over the last several episodes, we've systematically dissected the evidence that defines modern CNS oncology. Today, we put that knowledge to the test. These episodes will follow a mock oral board examination. I will present comprehensive case blocks, covering different clinical scenarios and then pose a series of questions designed to test your knowledge across all core competencies. Pause after each question to formulate your own structured response before I provide the model answer and a key teaching pearl.

Episode 19D: Benign P3d: Rare Benign Rapid Review.Needs editing

This is Episode 19c: Benign P3c: Trigeminal Neuralgia – SRS for Functional Pain.Needs editing

This is Episode 19b: Benign P3b: AVM Part 2 - SRS Technique, Doses & Toxicity. Needs editing

This is Episode 19a, the first in our new two-part series on a fascinating and challenging benign condition: Arteriovenous Malformations, or AVMs. To build a foundational understanding of arteriovenous malformations (AVMs) by covering their biology and risk factors, applying the Spetzler-Martin scale to assess surgical risk, calculating annual hemorrhage risk, and critically dissecting the controversial ARUBA trial.

In our last episode, we mastered the management of non-functioning pituitary adenomas, where the primary goal of radiation is long-term tumor control. Today, we tackle the more complex world of functional, or secreting, pituitary adenomas. Here, the clinical challenge is entirely different. Our goal is not just to control the size of the tumor, but to achieve biochemical control—to shut down the hormonal overproduction that causes debilitating syndromes like Cushing's disease and acromegaly. This episode will master the distinct, subtype-specific management of these tumors, focusing on their unique goals, the higher radiation doses required, and the differing timelines for hormonal normalization.